<DOC>
	<DOCNO>NCT03031834</DOCNO>
	<brief_summary>Patients diabetes mellitus definite autonomic peripheral neuropathy randomize receive quinapril treatment 2 year .</brief_summary>
	<brief_title>Efficacy Administration ACE-Inhibition Autonomic Peripheral Neuropathy Patients With Diabetes Mellitus</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<mesh_term>Quinapril</mesh_term>
	<criteria>Diabetes mellitus autonomic peripheral neuropathy Hypertension , coronary heart disease</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>